ArticleRheumatology and therapy2021

Efficacy of Long-Term Treatment with Once-Daily Baricitinib 2 mg in Patients with Active Rheumatoid Arthritis: Post Hoc Analysis of Two 24-Week, Phase III, Randomized, Controlled Studies and One Long-Term Extension Study.

Alvin F Wells et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.